Latest EU medtech regulatory reform proposals are mixed news for borderline product makers and distributors
This article was originally published in SRA
Executive Summary
Two pharmaceutical industry associations have voiced their views on the ongoing overhaul of the EU medtech regulatory system in light of the 25 September vote by European Parliament committee ENVI on the proposed Medical Device Regulation.